Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9122 |
High Similarity |
NPD3882 |
Suspended |
0.9116 |
High Similarity |
NPD2801 |
Approved |
0.9048 |
High Similarity |
NPD1934 |
Approved |
0.8889 |
High Similarity |
NPD1511 |
Approved |
0.8767 |
High Similarity |
NPD1512 |
Approved |
0.8733 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8705 |
High Similarity |
NPD943 |
Approved |
0.8705 |
High Similarity |
NPD1240 |
Approved |
0.8618 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8592 |
High Similarity |
NPD1510 |
Phase 2 |
0.8582 |
High Similarity |
NPD1607 |
Approved |
0.8511 |
High Similarity |
NPD230 |
Phase 1 |
0.8481 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8478 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8471 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8471 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8471 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8366 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8302 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8289 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8288 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8261 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8255 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8227 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8219 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.82 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8098 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8082 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8049 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8028 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8027 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8013 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7986 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7975 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7961 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7917 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7895 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7834 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7815 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7812 |
Intermediate Similarity |
NPD919 |
Approved |
0.781 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7763 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7748 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7718 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7708 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7702 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7698 |
Intermediate Similarity |
NPD9268 |
Approved |
0.764 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7632 |
Intermediate Similarity |
NPD2800 |
Approved |
0.763 |
Intermediate Similarity |
NPD228 |
Approved |
0.7628 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7622 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7616 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7613 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7613 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7613 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7613 |
Intermediate Similarity |
NPD5401 |
Approved |
0.761 |
Intermediate Similarity |
NPD37 |
Approved |
0.7607 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7552 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.755 |
Intermediate Similarity |
NPD6100 |
Approved |
0.755 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7547 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7547 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.75 |
Intermediate Similarity |
NPD9545 |
Approved |
0.75 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.747 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7469 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7468 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7419 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7414 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7405 |
Intermediate Similarity |
NPD920 |
Approved |
0.7403 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7381 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7376 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7368 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7312 |
Intermediate Similarity |
NPD824 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7292 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7278 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7266 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7255 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7235 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7215 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7205 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7197 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7153 |
Intermediate Similarity |
NPD17 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7097 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7095 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7091 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7086 |
Intermediate Similarity |
NPD411 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7069 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7055 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7041 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7027 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7025 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7025 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7012 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.6993 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6993 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD3266 |
Approved |
0.698 |
Remote Similarity |
NPD3267 |
Approved |
0.6978 |
Remote Similarity |
NPD3021 |
Approved |
0.6978 |
Remote Similarity |
NPD3022 |
Approved |
0.6974 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD1651 |
Approved |
0.6959 |
Remote Similarity |
NPD4749 |
Approved |
0.6957 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD2353 |
Approved |
0.6943
|
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |